HLA typing is used to match patients and donors for bone marrow or cord blood transplants. HLA antibody screening and crossmatch testing improve the safety of transplantation. Global HLA typing for the transplant market was valued at $0.57 billion in 2017 and is expected to reach $0.99 billion by 2025 with a CAGR of 7.1% during the forecast period from 2019-2025. The factors like technological advancements in the field of HLA typing and increased funding, research grants, & public-private investments and growing number of solid organ, soft-tissue, and stem cell transplantation procedures are driving the market growth. The factors like limited medical reimbursements for organ donation and transplantation procedures and the high cost of NGS & PCR-based devices are hindering the market growth. Technological shift from serological assays to gene-based HLA profiling are creating opportunities for market growth.
Research Study Objectives:
- Define, estimate, and forecast the HLA Typing for Transplant market statistics by product & service, technology, application, end user and regions concerning the individual growth drivers, market trends and their contribution toward the HLA Typing for Transplant market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific, South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the HLA Typing for Transplant Market Analysis report.
- Analysis and conclusions on the future HLA Typing for Transplant market outlook.
Top-down and bottom-up approaches are used to validate the HLA Typing for Transplant Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary sources;
databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The HLA Typing for Transplant Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the HLA Typing for Transplant market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The HLA Typing for Transplant market segmentation is as follows:
By Product & Service
- Instruments
- Software and Services
- Reagents and Consumables
By Technology
- Non-Molecular Assays
- Mixed Lymphocyte Culture Assays
- Serological Assays
- Molecular Assays
- Sequencing-Based Molecular Assays
- Next-Generation Sequencing
- Sanger Sequencing
- PCR-Based Molecular Assays
- Sequence-Specific Oligonucleotide-PCR
- Sequence-Specific Primer-PCR
By Application
- Research Applications
- Diagnostic Applications
- Others
By End User
- Commercial Service Providers
- Research Laboratories and Academic Institutes
- Hospitals & Transplant Centers
- Others
Geographical Analysis:
HLA Typing for Transplant Market is segmented by geography into North America, South America, Europe, Asia Pacific and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. The Asia Pacific is further categorised by countries into China, India, Japan, South
Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations. In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the HLA Typing for Transplant Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global HLA Typing for Transplant Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant HLA Typing for Transplant market players, such as
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- Affymetrix, Inc.
- Hoffmann-LA-Roche Ltd.
- Luminex Corporation
- Along with these companies, many other companies are considered in the report while analysing the Global HLA Typing for Transplant market competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
